Outset Medical begins selling TabloCart again after FDA nod
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.
Stay updated with breaking news from Sam Eiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.
IRhythm (Nasdaq: IRTC) shares dipped slightly today on first-quarter results that topped the consensus sales forecast.
Abbott (NYSE: ABT) announced today that the FDA approved its Espirit everolimus-eluting resorbable scaffold system.
The tech giant said the decision to ban the watches were made relying on Masimo patents that were “purely hypothetical” when filing the complaint in 2021.
Outset Medical (Nasdaq: OM) shares ticked up after BTIG analysts initiated coverage with a "Buy" rating for the home hemodialysis company.